These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24658193)

  • 21. Extended epoetin alfa dosing in chronic kidney disease patients: a retrospective review.
    Germain M; Ram CV; Bhaduri S; Tang KL; Klausner M; Curzi M
    Nephrol Dial Transplant; 2005 Oct; 20(10):2146-52. PubMed ID: 15985516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mortality in incident haemodialysis patients: time-dependent haemoglobin levels and erythropoiesis-stimulating agent dose are independent predictive factors in the ANSWER study.
    Fort J; Cuevas X; García F; Pérez-García R; Lladós F; Lozano J; Martín-Malo A;
    Nephrol Dial Transplant; 2010 Aug; 25(8):2702-10. PubMed ID: 20176608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comorbidity, anemia and response to erythropoiesis stimulating agents in chronic hemodialysis].
    Anaya S; Rivera F; Sánchez de la Nieta MD; Carreño A; Vozmediano C; Alcaide MP; Arambarri M; Nieto J; Caparrós G; Ferreras I
    Nefrologia; 2008; 28(2):186-92. PubMed ID: 18454709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iron supplementation in the non-dialysis chronic kidney disease (ND-CKD) patient: oral or intravenous?
    Macdougall IC
    Curr Med Res Opin; 2010 Feb; 26(2):473-82. PubMed ID: 20014980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A predictive algorithm for the management of anaemia in haemodialysis patients based on ESA pharmacodynamics: better results for less work.
    Lines SW; Lindley EJ; Tattersall JE; Wright MJ
    Nephrol Dial Transplant; 2012 Jun; 27(6):2425-9. PubMed ID: 22207330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anaemia in older people with chronic heart failure: The potential cost.
    Man-Fai Sim V; Nam MC; Riley S; Yousef Z; Hurley J; Cheung WY; O'Mahony S
    Technol Health Care; 2009; 17(5-6):377-85. PubMed ID: 20051617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost should be the principal determinant of choice of erythropoiesis-stimulating agent in chronic haemodialysis patients.
    Courtney AE; McNamee PT; Maxwell AP
    Nephron Clin Pract; 2007; 107(1):c14-9. PubMed ID: 17664890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of proactive iron and erythropoiesis-stimulating agent protocol implementation on achieving clinical guideline targets for anaemia in a satellite haemodialysis patient cohort.
    Yong K; Kairaitis L
    Nephrology (Carlton); 2010 Apr; 15(3):288-93. PubMed ID: 20470296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contemporary management of anaemia, erythropoietin resistance and cardiovascular risk in patients with advanced chronic kidney disease: a nationwide analysis.
    Evans M; Bower H; Cockburn E; Jacobson SH; Barany P; Carrero JJ
    Clin Kidney J; 2020 Oct; 13(5):821-827. PubMed ID: 33123358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease.
    Maddux FW; Shetty S; del Aguila MA; Nelson MA; Murray BM
    Ann Pharmacother; 2007 Nov; 41(11):1761-9. PubMed ID: 17895328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum erythropoietin concentrations and responses to anaemia in patients with or without chronic kidney disease.
    Artunc F; Risler T
    Nephrol Dial Transplant; 2007 Oct; 22(10):2900-8. PubMed ID: 17556407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the Handling Erythropoietin Resistance With Oxpentifylline (HERO) trial.
    Johnson DW; Pascoe EM; Badve SV; Dalziel K; Cass A; Clarke P; Ferrari P; McDonald SP; Morrish AT; Pedagogos E; Perkovic V; Reidlinger D; Scaria A; Walker R; Vergara LA; Hawley CM;
    Am J Kidney Dis; 2015 Jan; 65(1):49-57. PubMed ID: 25115616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends in haemoglobin, erythropoietin-stimulating agents and iron use in Swedish chronic kidney disease patients between 2008 and 2013.
    Evans M; Suttorp MM; Bellocco R; Hoekstra T; Qureshi AR; Dekker FW; Carrero JJ
    Nephrol Dial Transplant; 2016 Apr; 31(4):628-35. PubMed ID: 26243782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ORAMA: a study to investigate EBPG impact on renal anaemia - design and baseline data.
    Locatelli F; Covic A; Macdougall IC; Wiecek A;
    J Nephrol; 2008; 21(4):592-603. PubMed ID: 18651551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An open-label, randomized, multicenter, controlled study of epoetin alfa for the treatment of anemia of chronic kidney disease in the long term care setting.
    Patel M; Thimons DG; Winston JL; Langholff W; McGowan T
    J Am Med Dir Assoc; 2012 Mar; 13(3):244-8. PubMed ID: 21450214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are haemoglobin levels adequate in patients with chronic kidney disease (CKD) stage 2-4?
    Trowbridge L; Kruger A; Arnold A; Butcher B; Bradley J
    J Ren Care; 2013 Dec; 39(4):194-9. PubMed ID: 23782818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [IV iron or oral iron in anaemic patient with CKD].
    Frimat L; Thilly N; Boini S
    Nephrol Ther; 2006 Nov; 2 Suppl 5():S347-9. PubMed ID: 17373282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence, incidence, and treatment of anaemia in patients with non-dialysis-dependent chronic kidney disease: findings from a retrospective real-world study in Italy.
    Minutolo R; Grandaliano G; Di Rienzo P; Snijder R; Degli Esposti L; Perrone V; Todorova L
    J Nephrol; 2023 Mar; 36(2):347-357. PubMed ID: 36370331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anaemia in patients with chronic kidney disease: management with epoetin beta in primary care setting in New Zealand.
    Madhan KK; Chamberlain M; Anderson E
    Nephrology (Carlton); 2008 Oct; 13(5):428-32. PubMed ID: 18331435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High prevalence of anaemia and limited use of therapy in cancer patients: a Belgian survey (Anaemia Day 2008).
    Verbeke N; Beguin Y; Wildiers H; Canon JL; Bries G; Bosly A; Van Belle S
    Support Care Cancer; 2012 Jan; 20(1):23-8. PubMed ID: 21107613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.